Neurol. praxi. 2016;17(5):293-297 | DOI: 10.36290/neu.2016.061

Radiotherapy in brain metastases treatment

MUDr. Ludmila Hynková1,2, prof. MUDr. Pavel Šlampa, CSc.1,2, doc. MUDr. Radim Jančálek, Ph.D.3,4
1 Klinika radiační onkologie, Masarykův onkologický ústav, Brno
2 Klinika radiační onkologie, LF MU Brno
3 Neurochirurgická klinika FN u sv. Anny v Brně, Brno
4 Neurochirurgická klinika FN u sv. Anny v Brně, LF MU Brno

Brain metastases are ten times more common than primary brain tumors. Patients with brain metastases represent a large group indicated to radiation treatment. This article summarizes the most commonly used radiotherapy techniques, as well as side effects and the ways of their treatment.

Keywords: brain metastases, whole brain radiotherapy, radiosurgery, side effects

Published: November 7, 2016  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Hynková L, Šlampa P, Jančálek R. Radiotherapy in brain metastases treatment. Neurol. praxi. 2016;17(5):293-297. doi: 10.36290/neu.2016.061.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Ayoma H, Shirato H, Tago M, Nakagawa K, Toyoda T, Hatano K, Keniyo M, Oya A, Hirota H, Kunieda E, Inomata T, Hayakawa K, Katoh N, Kobashi G. Stereotactic radiosurgery plus whole-brain radiation therapy vs stereotactic radiosurgery or radiosurgery alone for treatment of brain metastases: a randomized controlled trial. JAMA 2006; 295(21): 2483-2491. Go to original source... Go to PubMed...
    2. Bezjak A, Adam J, Barton R, Panzarella T, Laperriere N, Wong CS, Mason W, Buckley C, Levin w, McLean M, Wu JS, Sia M, Kirkbride P. Symptom response after palliative radiotherapy for patients with brain metastases. Eur J Cancer 2002; 38(4): 478-496. Go to original source...
    3. Brown PD, Asher AL, Ballman KV, Farace E, Cerhan JH, Anderson KA, Ximara WC, Barker FG, Deming RL, Burri S, Menard C, Chung C. NCCTG N0574 (Alliance): a phase III randomized trial of whole brain radiation therapy (WBRT) in addition to radiosurgery (SRS) in patiens with 1 to 3 brain metastases. J Clin Oncol 2015; (suppl., abstr. LBA4). Go to original source...
    4. Brown PD, Pugh S, Laack NN, Wefel JF, Khuntia D, Meyers CH, Choucair A, Fox S, Suh JH, Roberge D, Kavadi V, Bentzen S, Mehta MP, Watkins-Bruner D. Memantine for the preventiv of cognitive dysfunction in patiens receiving whole-brain radiotherapy: a randomized, double-blind, placebo-controlled trial. Neuro Oncol 2013; 15(10): 1429-1437. Go to original source...
    5. DeAngelis LM, Currie VE, Kim JH, Krol G, O' Hehir MA, Farag FM, Young CW, Posner JB. The combined use of radiation therapy and lonitamide in the treatment of brain metastases. J Neurooncol 1989; 7: 241-247. Go to original source...
    6. Gaspar LE, Scott C, Murray K, Curran W. Validation of the RTOG recursive partitioning analysis (RPA) classification for brain metastases. Int J Radiat Oncol Biol Phys 2000; 47(4): 1001-1006. Go to original source...
    7. Gondi V, Pugh W, Tome A, Caine C, Corn B, Kanner A, Rowley H, Kundapur V, DeNittis A, Greenspoon JN, Konski AA, Bauman GS, Stah S, Shi W, Wendland M, Kachnic L, Mehta MP. "Preservation of memory with conformal avoidance of the hippocampal neural stem-cell compartment during whole-brain radiotherapy for brain metastases (RTOG 0933): a phase II multi-institutional trial". J Clin Oncol 2014; 32(34): 3810-3816. Go to original source... Go to PubMed...
    8. Gutierréz AN, Westerly DC, Tomé WA, Jaradat HM, Mackie TR, Bentzen SM, Khuntia D, Mehta MP. Whole brain radiotherapy with hippocampal avoidance and simultaneously integrated brain metastases boost: a planning study. Int J Radiat Oncol Biol Phys 2007; 69(2): 589-597. Go to original source...
    9. Hecht M, Zimmer L, Loquai C, Weishaupt C, Gutzmer R, Schuster B, Gleisner S, Schulze B, Goldinger SM, Berking C, Forschner A, Clemens P, Grabenbauer G, Muller-Brenne T, Bauch J, eich HT, Grabbel S, Schadendorf D, Schuller G, Kejkanoussi P, Semran S, Fietkau R, CDiestel LV, Heinzerling L. Radiosensitization by BRAF inhibitor therapy-mechanism and frequency of toxicity in melanoma patients. Ann Oncol 2015; 26: 1238-1244. Go to original source...
    10. Chang EL, Wefel JS, Hess KR, Allen PK, Lang FF, Kornguth DG, Arbuckle RB, Swint JM, Shin AS, Maor MH, Meyers CA. Neurocognition in patients with brain metastases treated with radiosurgery or radiosurgery plus whole-brain irradiation: a randomized controlled trial. Lancet Oncol 2009; 10(11): 1037-1034. Go to original source...
    11. Chao JH, Phillips R, Nickson JJ. Roentgen ray-therapy of cerebral metastases. Cancer 1954; 7(4): 682-689. Go to original source...
    12. Kazda T, Jancalek R, Pospisil P, Sevela O, Procházka T, Vrzal M, Burkon P, Slavik M, Hynkova L, Slampa P, Lack NN. Why and how to spare the hippocampus during brain radiotherapy: the developing role of hippocampal avoidance in cranial radiotherapy. Radiat Oncol 2014; 9: 139: doi: 10.1186/1748-717X-9-139. Go to original source...
    13. Kim DG, Lunsford LD. Current and Future Management of Brain Metastasis. Pittsburg: Karger 2012: 314 s. Go to original source...
    14. Kim SH, Wiel RJ. Treatment options for elderly patients with brain metastases from systematic cancer. Aging Health 2009; 5(3): 323-331. Go to original source...
    15. Lagerwaard FJ, van der Hoorn EA, Verbakel WF, Hansbeek CJ, Slotman BJ, Senan S. Whole-brain radiotherapy with simultaneous integrated boost to multiple brain metastases using volumetric modulated arc therapy. Int J Radiat Oncol Biol Phys 2009; 75(1): 253-259. Go to original source...
    16. Lang N, Sterzing F, Enk AH, Hassel JC. Cutis verticis gyrata-like skin toxicity during treatment of melanoma patients with BRAF inhibitor vemurafenib after whole-brain radiotherapy is a consequence of the development of multiple follicular cysts and milia. Strahlenther Oncol 2014; 190: 1080-1081. Go to original source...
    17. Lawrence YR, Li XA, el Naqa I, Hahn CA, Marks LB, Merchant TE, Dicker AP. Radiation-dose-volume effects in the brain. Int J Radiat Oncol Biol Phys 2010; 76(3): S 20-27. Go to original source...
    18. Lin X, DeAngelis LM. Treatment of Brain Metastases. J Clin Oncol 2015; 33(30): 3475-3484. Go to original source... Go to PubMed...
    19. Ling DC, Vargo JA, Wegner RE, Hahn CA, Marks LB, Merchant TE, Dicker AP, Flickinger JC, Burton SA, Engh'J, Amankulor N, Quinn AE, Ozhasoglu C, Heron DE. Postoperative stereotactic radiosurgery to the resection cavity for large brain metastases: clinical outcomes, predictors of intracranial failure, and implications for optimal patient selection. Neurosurgery 2015; 76(2): 150-156. Go to original source... Go to PubMed...
    20. Linskey M, Andrews W, Asher L, Burri SH, Kondziolka D, Robinson PD, Ammirati M, Cobbs CS, Gaspar LE, Loeffler JS, McDermott M, Mehta MP, Mikkelsen T, Olson JJ, Paleologos NA, Patchell RA, Ryken TC, Kalkanis SN. The role of stereotactic radiosurgery in the management of patients with newly diagnosed brain metastases: a systematic review and evidence based clinical practice guideline. J Neurooncol 2010; 96 (1): 45-68. Go to original source... Go to PubMed...
    21. Maldaun M, Aguiar P, Lang F, Suki D, Wildrick D, Sawaya R. Radiosurgery of brain metastases: critical review regarding complications. Neurosurg Rev 2008; 31(1): 1-9. Go to original source... Go to PubMed...
    22. Minniti G, Esposito V, Clarke E, Scaringi C, Bozzao A, Lanzetta G, DeSantis V, Valerianni M, Osti M, Enrici RM. Stereotactic radiosurgery in elderly patients with brain metastases. J Neurooncol 2013; 111(3): 319-325. Go to original source...
    23. Monje ML, Palmer T. Radiation injury and neurogenesis. Curr Opin Neurol 2003; 16(2): 129-134. Go to original source... Go to PubMed...
    24. Mulvenna PM, Nankivell MG, Barton R, Faivre-Finn C, Wilson P, Moore B. Whole brain radiotherapy for brain metastases from non-small lung cancer: Quality of life (QoL) and overall survival (OS) results from the UK Medical Research Council QUARTZ randomised clinical trial (ISRCTN 3826061). J Clin Oncol 2015; 33. Abstr 8005. Go to original source...
    25. Nayak L, Lee EQ, Wen PY. Epidemiology of brain metastases. Curr Oncol Rep 2012; 14(1): 48-54. Go to original source... Go to PubMed...
    26. Nieder C, Berberich W, Schnabel K. Tumor-related prognostic factors for remission of brain metastases after radiotherapy. Int J Radiat Oncol Biol Phys 1997; 39: 25-30. Go to original source...
    27. Pannullo SC, Fraser JF, Moliterno J, Cobb W, Stieg PE. Stereotactic radiosurgery: a meta-analysis of current therapeutic applications in neuro-oncologic disease. J Neurooncol 2011; 103(1): 1-17. doi: 10.1007/s11060-010-0360-0. Go to original source...
    28. Peißner W, Kocher M, Treuer H, Gillardon F. Ionizing radiation-induced apoptosis of proliferating stem cells in the dentate gyrus of the adult rat hippocampus. Molecular Brain Res 1999; 71(1): 61-68. Go to original source... Go to PubMed...
    29. Pospisil P, Kazda T, Bulik M, Dobiaskova M, Burkon P, Hynkova L, Slampa P, Jancalek R. Hippocampal proton MR spectroscopy as a novel approach in the assessment of radiation injury and the correlation to neurocognitive function impairment: initial experiences. Radiat Oncol 2015, 10:211 doi: 10.1186/s13014-015-0518-1. Go to original source...
    30. Regine WF, Scott C, Murray K, Curran W. Neurocognitive outcome in brain metastases patients treated with accelerated-fractionation vs. Accelerated - hypofractionated radiotherapy: an analysis from Radiation Therapy Oncology Groups Study 91-04. Int J Radiat Oncol Biol Phys 2001; 51(3): 711-717. Go to original source... Go to PubMed...
    31. Robbins JR, Ryu S, Kalkanis S, Cogan C, Rock J, Movsas B, Kim JH, Rosenblum M. Radiosurgery to the surgical cavity as adjuvant therapy for resected brain metastasis. Neurosurgery 2012; 71(5): 937-43. Go to original source... Go to PubMed...
    32. Ryken TC, McDermott M, Robinson PT, Ammirati M, Andrews DW, Asher AL, Burri SH, Cobbs CS, Gaspar LE, Kondziolka D, Linskey ME, Loeffler JS, Mehta MP, Mikkelsen T, Olson JJ, Paleoloqos NA, Patchell RA, Kalkanis SN. The role of steroids in the management of brain metastases: A systematic review and evidence-based clinical practice guideline. J Neurooncol 2010; 96: 103-104. Go to original source...
    33. Sahgal A, Ayoma H, Kocher M, Neupane B, Collette S, Tago M, Shaw P, Beyene J, Chang EL. Phase 3 trial of stereotactic radiosurgery with or without whole brain radiotherapy for 1 to 4 brain metastases: individual patient data meta-analysis. Int J Radiat Oncol Biol Phys 2015; 91(4): 710-714. Go to original source...
    34. Shin SM, Vatner RE, Tam M, Neupane B, Collette S, Taqo M, Shaw P, Beyene J, Chang LE. Resection followed by involved-field fractionated radiotherapy in the management of single brain metastases. Front Oncol 2015; 5: 206, doi: 10.3389/fonc.2015.00206. Go to original source... Go to PubMed...
    35. Sperduto PW, Kased N, Roberge D, Xu Z, Shanley R, Luo X, Snned PK, Chao ST, weil RJ, Suh J, Bhatt A, Jensen AW, Brown PD, Shih HA, Kirkpatrick J, Gaspar LE, Fiveash JB, Chiang V, Knisely J P.S, Sperduto CHM, Lin N, Mehta M. Summary report on the graded prognostic assessment: an accurate and facile diagnosis-specific tool to estimate survival for patients with brain metastases. J Clin Oncol 2012; 30(4): 419-425. Go to original source... Go to PubMed...
    36. Sturdza A, Millar BA, Bana N, Laperiere N, Pond G, Wong RK, Bezjak A. The use and toxicity of steroids in the management of patients with brain metastases. Support Care Cancer 2008; 16(9): 1041-8. Go to original source... Go to PubMed...
    37. Sugahara T, Korogi Y, Tomiguchi S, Shigematsu Y, Ikushima I, Kira T, Liang L, Ushio Y, Takahashi M. Posttherapeutic Intraaxial Brain Tumor: The value of perfusion sensitive contrast enhanced MR imaging for differentiating tumor recurrence from nonneoplastic contrast - enhancing tissue. Am J Neuroradiol 2000; 21(5): 901-909.
    38. Šimonová G. Mozkové metastázy In Radiochirurgie gama nožem. Principy a neurochirurgické aplikace. R. Liščák a kol. Praha: Grada Publishing 2009: 151-164.
    39. Tsao MN, Lloyd NS, Wong RKS, Rakovitch E, Chow E, Laperriere N; Supportice care Guidelines Group of cancer Care Ontario's Program in Evidence-based Care. Radiotherapeutic management of brain metastases: a systematic review and meta-analysis. Cancer Treat Rev 2005; 31(4): 256-73. Go to original source...
    40. Tsao M, Xu W, Sahgal A. A meta-analysis evaluating stereotactic radiosurgery, whole-brain radiotherapy, or both for patients presenting with a limited number of brain metastases. Cancer 2012; 118(9): 2486-2493. Go to original source... Go to PubMed...
    41. Viani GA, Manta GB, Fonseca EC, De fendi LI, Afonso SL, Stefano EJ. Whole brain radiotherapy with radiosenzitizer for brain metastases. J Exp Clin Cancer Res 2009; 28:1, doi: 10.1186/1756-9966-28-1. Go to original source...
    42. Watanabe S, Yamamoto M, Sato Y, Barford BE. Stereotactic radiosurgery for brain metastases: a case-matched study comparing treatment results for patients 80 years of age or older versus patients 65-79 years of age. J Neurosurg 2014; 121(5): 1148-1152. Go to original source...
    43. Yamamoto M, Serizawa T, Shuto T, Akabene A, Hiquchi Y, Kawaqishi J, Yamanak K. Stereotactic radiosurgery for patients with multiple brain metastases (JLGKO901): a multi-institutional prospective observational study. Lancet Oncol 2014; 15(4): 387-395. Go to original source...

    Return to the content


    Neurology for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.